Screening method identifies leukemia drug candidates from more than 4 million compounds

A cancer cell behaves differently from a healthy cell, with unique features that enable rapid growth and bypass quality controls. Rice University's Natasha Kirienko is interested in finding these unique features and exploiting them to advance cancer treatments. In a paper recently published in the journal Leukemia, her team used a new screening method to identify drugs that could target these unique features, or vulnerabilities, of cancer cells without unduly harming healthy cells.

Read it at Medical Xpress ↗

← Front page